Evidence map›Paper›PMID 41040508›Full record

ArticleFrontiers in oncology2025

Exploring 2D and 3D radiomic models for predicting microvascular invasion in hepatocellular carcinoma: a novel perspective on tumor heterogeneity.

Zexin Yin, Meilong Wu, Youyao Li, Zhike Li, Shiyun Bao, Liping Liu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zexin YinDepartment of Pancreatic Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
Meilong WuDepartment of Hepatobiliary and Pancreatic Surgery, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Youyao LiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Zhike LiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Shiyun BaoDepartment of Hepatobiliary and Pancreatic Surgery, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Liping LiuDepartment of Hepatobiliary and Pancreatic Surgery, The Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to develop models for predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients prior to surgery using two-dimensional (2D) and three-dimensional (3D) radiomics features from contrast-enhanced computed tomography (CT). The study compares the predictive performance of various models and explores the potential of radiomics to capture tumor spatial heterogeneity. Materials and methods: A total of 150 hepatocellular carcinoma (HCC) patients who underwent contrast-enhanced CT examination and curative resection were included in this study. 2D features from the largest cross-sectional slice, as well as 3D radiomic features, were extracted from the non-contrast (NC), arterial phase (AP), portal venous phase (PVP), and balanced phase (BP) images. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) algorithm, and predictive models were constructed using logistic regression and XGBoost machine learning algorithms. The predictive performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: The 2D BP model (AUC = 0.801) and 3D PVP model (AUC = 0.876) showed superior performance among single-sequence models. The 2D multi-sequence model (AUC = 0.851) outperformed the 3D combined model (AUC = 0.811). Radiomics-based models outperformed clinical feature-based models, and combining radiomics scores with clinical features improved prediction accuracy. However, 3D models did not significantly outperform 2D models. Conclusion: Both 2D and 3D radiomics models are effective for predicting MVI in HCC patients preoperatively. While the 3D model captures spatial heterogeneity, the 2D model excels at capturing local texture features. This study provides new insights into radiomics in HCC, contributing to its clinical application and standardization.

Indexed as

intratumoral heterogeneitymachine learningmicrovascular invasionradiomicstwo-dimensional and three-dimensional models

Identifiers

PMID41040508
PMCPMC12484195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.